| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.19▼ | 7.17▼ | 7.08▲ | 7.34▼ | 8.08▼ |
| MA10 | 7.19▼ | 7.05▲ | 7.18▼ | 8.00▼ | 8.50▼ |
| MA20 | 7.18▼ | 7.19▼ | 7.28▼ | 8.34▼ | 10.06▼ |
| MA50 | 7.06▲ | 7.28▼ | 7.65▼ | 8.79▼ | 12.13▼ |
| MA100 | 7.14▲ | 7.73▼ | 8.22▼ | 10.20▼ | 31.48▼ |
| MA200 | 7.27▼ | 8.24▼ | 8.45▼ | 11.55▼ | 42.75▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | 0.018▲ | 0.010▲ | -0.127▼ | 0.022▲ |
| RSI | 54.953▲ | 46.935▼ | 40.025▼ | 22.488▼ | 25.050▼ |
| STOCH | 57.155 | 68.975 | 27.300 | 10.419▼ | 5.838▼ |
| WILL %R | -80.000▼ | -52.991 | -52.991 | -86.893▼ | -95.091▼ |
| CCI | -37.917 | 63.318 | -22.282 | -111.631▼ | -118.299▼ |
| CDL | $SITC Evening Star Candlestick Pattern Detected | Set Alert |
|
Thursday, November 06, 2025 01:30 PM
CX-2051 Phase 1 data update on track for Q1 2026 - - CX-2051 Phase 1b CRC combination study with bevacizumab to start in Q1 2026 - - Positive CX-801 Phase 1 monotherapy biomarker data at SITC 2025 ...
|
|
Thursday, November 06, 2025 06:25 AM
Data to be presented at SITC Annual Meeting and MRF Brain Metastases Summit 4.0 on Nov. 9, 2025.
|
|
Thursday, November 06, 2025 04:48 AM
Recall, at the 2025 SNO/ASCO CNS Metastases conference in August, ReSPECT-LM Phase 1 single dose escalation trial data showed: REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/25 | 7.355 | 7.355 | 6.89 | 7.16 | 2,896,475 |
| 05/11/25 | 7.41 | 7.48 | 7.37 | 7.47 | 821,152 |
| 04/11/25 | 7.25 | 7.41 | 7.25 | 7.40 | 891,227 |
| 03/11/25 | 7.25 | 7.345 | 7.16 | 7.32 | 1,007,318 |
| 31/10/25 | 7.4002 | 7.47 | 7.28 | 7.33 | 1,224,452 |
| 30/10/25 | 8.47 | 8.525 | 8.345 | 8.38 | 1,101,757 |
| 29/10/25 | 8.64 | 8.64 | 8.41 | 8.50 | 1,257,487 |
| 28/10/25 | 8.89 | 8.905 | 8.65 | 8.66 | 1,276,824 |
| 27/10/25 | 8.885 | 8.91 | 8.77 | 8.91 | 1,150,159 |
| 24/10/25 | 8.80 | 8.89 | 8.675 | 8.85 | 1,290,461 |
|
|
||||
|
|
||||
|
|